The latest Investing Matters Podcast episode featuring Jeremy Skillington, CEO of Poolbeg Pharma has just been released. Listen here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksBurford Capital Regulatory News (BUR)

Share Price Information for Burford Capital (BUR)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 1,226.00
Bid: 0.00
Ask: 0.00
Change: 0.00 (0.00%)
Spread: 2.00 (0.163%)
Open: 0.00
High: 0.00
Low: 0.00
Prev. Close: 1,226.00
BUR Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Transaction in Own Shares

21 Mar 2024 07:00

RNS Number : 6830H
Burford Capital Limited
21 March 2024
 

March 21, 2024

 

 

 

Transaction In Own Shares

 

Burford Capital Limited (the "Company"), the leading global finance and asset management firm focused on law, today announces that, in accordance with the terms of its program announced on March 18, 2024 to purchase its ordinary shares, no par value per share ("Ordinary Shares"), up to a maximum aggregate amount of £5.0 million (the "Program") in connection with future obligations under the Company's Deferred Compensation Plan, the Company purchased the following number of Ordinary Shares through Numis Securities Limited ("Numis").

 

Date of purchase:

March 20, 2024

Aggregate number of Ordinary Shares purchased:

46,461

Lowest price paid per Ordinary Share (GBp):

1130.00

Highest price paid per Ordinary Share (GBp):

1170.00

Volume weighted average price paid per Ordinary Share (GBp):

1149.8569

 

Ordinary Shares purchased pursuant to the Program will be initially held by the Company in treasury. Following the purchase and settlement of these Ordinary Shares, the Company's issued ordinary share capital is 219,316,028, of which 441,464 Ordinary Shares are held in treasury and do not have any voting rights. Therefore, the total number of voting rights in the Company, excluding treasury shares, will be 218,874,564 after giving effect to the purchases described above. This figure for the total number of voting rights may be used by shareholders as the denominator for the calculations by which they will determine if they are required to notify their interest in the Company under the FCA's Disclosure Guidance and Transparency Rules.

 

In accordance with Article 5(1)(b) of the UK version of Regulation (EU) No. 596/2014 which is part of UK law by virtue of the European Union (Withdrawal) Act 2018, the table below contains detailed information with respect to the individual trades made by Numis as part of the Program.

 

Individual trades information:

 

Number of Ordinary Shares purchased

Transaction price (pence per Ordinary Share)

Time of transaction (GMT)

Trading venue

38

1146.00

08:23:47

AIMX

362

1150.00

08:29:53

AIMX

77

1150.00

08:29:53

AIMX

100

1150.00

08:40:20

AIMX

398

1150.00

08:40:20

AIMX

290

1150.00

08:40:20

AIMX

376

1149.00

09:29:24

AIMX

379

1146.00

10:12:18

AIMX

9

1143.00

10:13:34

AIMX

396

1143.00

10:13:34

AIMX

430

1140.00

10:26:45

AIMX

7

1140.00

10:26:58

AIMX

53

1140.00

10:26:58

AIMX

15

1140.00

10:26:58

AIMX

10

1140.00

10:26:58

AIMX

53

1140.00

10:26:58

AIMX

14

1140.00

10:26:59

AIMX

396

1139.00

10:27:11

AIMX

40

1137.00

10:33:19

AIMX

317

1137.00

10:47:51

AIMX

370

1137.00

10:47:51

AIMX

394

1140.00

10:57:09

AIMX

62

1140.00

10:57:09

AIMX

441

1140.00

10:57:09

AIMX

6

1140.00

10:57:43

AIMX

13

1140.00

10:57:43

AIMX

8

1140.00

10:57:47

AIMX

13

1140.00

10:57:47

AIMX

395

1140.00

10:58:18

AIMX

7

1140.00

11:08:33

AIMX

391

1140.00

11:19:58

AIMX

168

1139.00

11:20:00

AIMX

270

1139.00

11:20:00

AIMX

255

1138.00

11:30:20

AIMX

130

1138.00

11:30:20

AIMX

20

1140.00

11:52:58

AIMX

8

1140.00

11:52:59

AIMX

375

1140.00

11:52:59

AIMX

8

1140.00

11:53:03

AIMX

16

1140.00

11:53:08

AIMX

265

1140.00

11:54:08

AIMX

126

1140.00

11:54:08

AIMX

10

1140.00

11:55:06

AIMX

13

1140.00

11:55:06

AIMX

216

1140.00

11:56:07

AIMX

82

1140.00

11:56:07

AIMX

409

1138.00

11:57:44

AIMX

439

1138.00

11:57:44

AIMX

296

1142.00

12:59:09

AIMX

416

1141.00

13:00:09

AIMX

604

1140.00

13:00:09

AIMX

400

1139.00

13:00:11

AIMX

415

1134.00

13:02:58

AIMX

439

1133.00

13:02:58

AIMX

102

1133.00

13:24:11

AIMX

262

1133.00

13:24:11

AIMX

273

1136.00

13:30:24

AIMX

13

1136.00

13:30:24

AIMX

450

1135.00

13:30:41

AIMX

365

1132.00

13:30:41

AIMX

999

1130.00

13:30:41

AIMX

396

1130.00

13:30:41

AIMX

748

1130.00

13:30:41

AIMX

488

1130.00

13:30:41

AIMX

323

1130.00

13:30:41

AIMX

800

1140.00

13:41:07

AIMX

663

1140.00

13:41:07

AIMX

524

1140.00

13:42:09

AIMX

6

1143.00

13:50:14

AIMX

8

1143.00

13:50:14

AIMX

640

1143.00

13:50:14

AIMX

9

1143.00

13:50:14

AIMX

45

1143.00

13:50:14

AIMX

377

1143.00

13:50:14

AIMX

401

1144.00

13:53:07

AIMX

216

1144.00

13:53:07

AIMX

40

1144.00

13:53:07

AIMX

39

1144.00

13:53:07

AIMX

49

1144.00

13:53:07

AIMX

55

1144.00

13:53:07

AIMX

300

1149.00

14:01:43

AIMX

547

1149.00

14:01:43

AIMX

400

1150.00

14:02:59

AIMX

20

1150.00

14:02:59

AIMX

424

1149.00

14:03:30

AIMX

350

1148.00

14:03:30

AIMX

13

1148.00

14:03:30

AIMX

90

1148.00

14:03:31

AIMX

13

1148.00

14:03:31

AIMX

386

1148.00

14:09:11

AIMX

215

1148.00

14:09:44

AIMX

13

1148.00

14:09:44

AIMX

121

1147.00

14:12:25

AIMX

262

1147.00

14:12:25

AIMX

469

1146.00

14:12:25

AIMX

458

1145.00

14:12:34

AIMX

100

1146.00

14:20:43

AIMX

315

1146.00

14:20:43

AIMX

10

1147.00

14:25:40

AIMX

1830

1149.00

14:34:34

AIMX

696

1149.00

14:34:34

AIMX

207

1149.00

14:34:34

AIMX

319

1149.00

14:34:34

AIMX

141

1149.00

14:35:56

AIMX

288

1149.00

14:35:56

AIMX

11

1151.00

14:44:36

AIMX

300

1153.00

14:49:44

AIMX

384

1153.00

14:49:44

AIMX

300

1153.00

14:49:44

AIMX

1838

1153.00

14:49:44

AIMX

613

1153.00

14:49:44

AIMX

388

1157.00

14:56:07

AIMX

358

1157.00

14:56:07

AIMX

383

1157.00

14:56:07

AIMX

388

1156.00

14:58:54

AIMX

49

1155.00

14:58:58

AIMX

301

1155.00

14:58:58

AIMX

326

1155.00

14:58:58

AIMX

116

1155.00

14:58:58

AIMX

313

1158.00

15:09:55

AIMX

62

1158.00

15:09:55

AIMX

219

1158.00

15:09:55

AIMX

394

1158.00

15:09:55

AIMX

18

1158.00

15:09:55

AIMX

148

1158.00

15:09:55

AIMX

262

1158.00

15:09:55

AIMX

9

1158.00

15:09:55

AIMX

137

1158.00

15:09:55

AIMX

387

1157.00

15:09:55

AIMX

188

1157.00

15:09:55

AIMX

16

1162.00

15:14:58

AIMX

372

1162.00

15:15:29

AIMX

1300

1164.00

15:25:37

AIMX

537

1164.00

15:25:37

AIMX

21

1165.00

15:28:42

AIMX

58

1165.00

15:29:02

AIMX

516

1165.00

15:29:02

AIMX

68

1165.00

15:29:07

AIMX

57

1165.00

15:31:02

AIMX

400

1165.00

15:31:02

AIMX

144

1165.00

15:31:02

AIMX

106

1167.00

15:35:54

AIMX

200

1167.00

15:35:54

AIMX

232

1167.00

15:35:54

AIMX

420

1166.00

15:36:48

AIMX

385

1166.00

15:43:33

AIMX

399

1166.00

15:43:33

AIMX

513

1165.00

15:43:33

AIMX

17

1165.00

15:43:33

AIMX

66

1168.00

15:47:09

AIMX

95

1168.00

15:47:09

AIMX

308

1168.00

15:57:09

AIMX

378

1168.00

15:57:09

AIMX

418

1168.00

15:57:09

AIMX

365

1168.00

15:57:09

AIMX

383

1168.00

15:57:09

AIMX

303

1167.00

15:57:09

AIMX

344

1167.00

15:57:09

AIMX

49

1167.00

15:57:09

AIMX

27

1169.00

16:01:50

AIMX

355

1169.00

16:01:50

AIMX

50

1169.00

16:03:35

AIMX

124

1169.00

16:03:36

AIMX

236

1169.00

16:03:36

AIMX

27

1169.00

16:03:36

AIMX

1000

1170.00

16:08:28

AIMX

350

1170.00

16:08:28

AIMX

130

1170.00

16:08:28

AIMX

100

1170.00

16:08:28

AIMX

182

1170.00

16:08:28

AIMX

 

 

For further information, please contact:

 

Burford Capital Limited

For investor and analyst inquiries:

Robert Bailhache, Head of Investor Relations, EMEA and Asia - email

+44 (0)20 3530 2023

Jim Ballan, Head of Investor Relations, Americas - email

+1 (646) 793 9176

For press inquiries:

David Helfenbein, Vice President, Public Relations - email

+1 (212) 235 6824

Deutsche Numis - NOMAD and Joint Broker

+44 (0)20 7260 1000

Giles Rolls

Charlie Farquhar

Jefferies International Limited - Joint Broker

+44 (0)20 7029 8000

Graham Davidson

James Umbers

Berenberg - Joint Broker

+44 (0)20 3207 7800

Toby Flaux

James Thompson

Yasmina Benchekroun

 

 

 

About Burford Capital

Burford Capital is the leading global finance and asset management firm focused on law. Its businesses include litigation finance and risk management, asset recovery and a wide range of legal finance and advisory activities. Burford is publicly traded on the New York Stock Exchange (NYSE: BUR) and the London Stock Exchange (LSE: BUR), and it works with companies and law firms around the world from its offices in New York, London, Chicago, Washington, DC, Singapore, Dubai, Sydney and Hong Kong.

 

For more information, please visit www.burfordcapital.com.

 

 

This announcement does not constitute an offer to sell or the solicitation of an offer to buy any ordinary shares or other securities of Burford.

 

This announcement does not constitute an offer of any Burford private fund. Burford Capital Investment Management LLC, which acts as the fund manager of all Burford private funds, is registered as an investment adviser with the US Securities and Exchange Commission. The information provided in this announcement is for informational purposes only. Past performance is not indicative of future results. The information contained in this announcement is not, and should not be construed as, an offer to sell or the solicitation of an offer to buy any securities (including, without limitation, interests or shares in any of Burford private funds). Any such offer or solicitation may be made only by means of a final confidential private placement memorandum and other offering documents.

 

Forward-looking statements

This announcement contains "forward-looking statements" within the meaning of Section 21E of the US Securities Exchange Act of 1934, as amended, regarding assumptions, expectations, projections, intentions and beliefs about future events. These statements are intended as "forward-looking statements". In some cases, predictive, future-tense or forward-looking words such as "aim", "anticipate", "believe", "continue", "could", "estimate", "expect", "forecast", "guidance", "intend", "may", "plan", "potential", "predict", "projected", "should" or "will" or the negative of such terms or other comparable terminology are intended to identify forward-looking statements, but are not the exclusive means of identifying such statements. In addition, Burford and its representatives may from time to time make other oral or written statements that are forward-looking, including in its periodic reports that Burford files with, or furnishes to, the US Securities and Exchange Commission, other information made available to Burford's security holders and other written materials. By their nature, forward-looking statements involve known and unknown risks, uncertainties and other factors because they relate to events and depend on circumstances that may or may not occur in the future. Burford cautions that forward-looking statements are not guarantees of future performance and are based on numerous assumptions, expectations, projections, intentions and beliefs and that Burford's actual results of operations, including its financial position and liquidity, and the development of the industry in which it operates, may differ materially from (and be more negative than) those made in, or suggested by, the forward-looking statements contained in this announcement. Significant factors that may cause actual results to differ from those Burford expects include, among others, those discussed under "Risk Factors" in Burford's annual report on Form 20-F for the year ended December 31, 2022 filed with the US Securities and Exchange Commission on May 16, 2023 and other reports or documents that Burford files with, or furnishes to, the US Securities and Exchange Commission from time to time. In addition, even if Burford's results of operations, including its financial position and liquidity, and the development of the industry in which it operates are consistent with the forward-looking statements contained in this announcement, those results of operations or developments may not be indicative of results of operations or developments in subsequent periods.

 

Except as required by law, Burford undertakes no obligation to update or revise the forward-looking statements contained in this announcement, whether as a result of new information, future events or otherwise.

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
POSFLFSDVDIIFIS
Date   Source Headline
16th Apr 20243:30 pmRNSHolding(s) in Company
10th Apr 202412:00 pmRNSNotice of Retail Shareholder Call on June 20, 2024
10th Apr 202412:00 pmRNSIssuance of New Shares in Connection With LTIP
10th Apr 202412:00 pmRNSNotice of 2024 AGM
3rd Apr 20244:30 pmRNSDirector/PDMR Shareholdings & Ownership Update
28th Mar 202411:00 amRNSAvailability of 2023 Annual Report
28th Mar 20247:00 amRNSTransaction in Own Shares
27th Mar 20244:45 pmRNSNotification of Transactions by PDMRs
27th Mar 20247:00 amRNSTransaction in Own Shares
26th Mar 20247:00 amRNSTransaction in Own Shares
25th Mar 20247:00 amRNSTransaction in Own Shares
22nd Mar 20247:00 amRNSTransaction in Own Shares
21st Mar 20247:00 amRNSTransaction in Own Shares
18th Mar 20244:00 pmRNSIntended Purchases of Ordinary Shares
14th Mar 202411:00 amRNSAnnual results for year ended December 31, 2023
7th Mar 20245:30 pmRNSHolding(s) in Company
7th Mar 20242:00 pmRNSNotice of 2023 Results & Results Call Details
30th Jan 20244:15 pmRNSClosing of Private Offering of Senior Notes
18th Jan 202412:00 pmRNSPamela Corrie Appointed as Board Director
17th Jan 20247:00 amRNSPricing and Upsizing of Senior Notes Offering
16th Jan 202412:45 pmRNSPrivate Offering of Senior Notes
3rd Jan 202412:00 pmRNSIssuance of New Shares in Connection with LTIP
22nd Nov 202312:00 pmRNSDirector/PDMR Shareholding
16th Nov 202312:00 pmRNSSterling Conversion Rate for 2023 Interim Dividend
9th Nov 202312:00 pmRNS3Q23 Results & Quarterly Report
3rd Nov 20237:05 amRNSNotice of 3Q23 Results & Results Call Details
9th Oct 202312:00 pmRNSIssuance of New Shares in Connection with LTIP
9th Oct 202311:45 amRNSExpansion and Further Extension of SWF Arrangement
27th Sep 20235:30 pmRNSDirector/PDMR Shareholding
27th Sep 20237:00 amRNSTransaction in Own Shares
26th Sep 20237:00 amRNSTransaction in Own Shares
25th Sep 20237:00 amRNSTransaction in Own Shares
22nd Sep 20237:00 amRNSTransaction in Own Shares
21st Sep 20237:00 amRNSTransaction in Own Shares
19th Sep 20231:30 pmRNSTransaction in Own Shares
13th Sep 202312:00 pmRNS2Q23 Results & Quarterly Report
11th Sep 20237:00 amRNSStatement on YPF Damages Ruling
8th Sep 20234:30 pmRNSSuspension - Burford Capital Limited
8th Sep 20234:09 pmRNSStatement re Petersen and Eton Park Matters
31st Aug 20232:00 pmRNSNotice of 2Q23 Results Call Details
25th Aug 20237:00 amRNSUS SEC Closes Comment Letter Review
9th Aug 20232:00 pmRNSDirector/PDMR Shareholding
12th Jul 202310:37 amRNSResult of AGM
7th Jul 202312:45 pmRNSPricing of Early Redemption of 2024 Bonds
4th Jul 20235:00 pmRNSTransaction in Own Shares
3rd Jul 20232:00 pmRNSCompletion of Share Purchases & PDMR Transactions
29th Jun 202311:14 amRNSIntended Purchases of Ordinary Shares
26th Jun 20236:00 pmRNSDirector/PDMR Shareholding
26th Jun 20232:08 pmRNSUpdate & Release Date for 2Q23 Results
26th Jun 20232:07 pmRNSNotice of Early Redemption of Bonds due 2024

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.